Engineering network-based dynamic features to predict drug sensitivity
Talk, Peter MacCallum Cancer Centre, Melbourne, Melbourne, Victoria (Australia)
Computational discovery of cancer drug response biomarkers typically employs machine learning pipelines to analyse large pharmacogenomic datasets. However, these -omics datasets, while extensive, lack critical information about intracellular protein signalling dynamics, which can determine drug response outcomes. The static nature of these datasets thus limits their ability to predict drug response mechanistically.
